Log in to save to my catalogue

Completed suicides of citalopram users—the role of CYP genotypes and adverse drug interactions

Completed suicides of citalopram users—the role of CYP genotypes and adverse drug interactions

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2098291355

Completed suicides of citalopram users—the role of CYP genotypes and adverse drug interactions

About this item

Full title

Completed suicides of citalopram users—the role of CYP genotypes and adverse drug interactions

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

International journal of legal medicine, 2019-03, Vol.133 (2), p.353-363

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Depression is known to be a risk factor for suicide. Currently, the most used antidepressants are selective serotonin reuptake inhibitors (SSRIs). Not all users, however, benefit from them. In such cases, treatment failure can be explained in part by genetic differences. In this study, we investigated the role of pharmacogenetic factors in citalopr...

Alternative Titles

Full title

Completed suicides of citalopram users—the role of CYP genotypes and adverse drug interactions

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2098291355

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2098291355

Other Identifiers

ISSN

0937-9827

E-ISSN

1437-1596

DOI

10.1007/s00414-018-1927-0

How to access this item